Skip to main content
. 2019 Nov 19;9:1176. doi: 10.3389/fonc.2019.01176

Figure 1.

Figure 1

The expression of miR-9-5p and FOXP2 in glioblastoma and patients' survival. (A) Cases are divided into two groups according to the expression of miR-9-5p in GBM. (B) Cases are divided into two groups according to the expression of FOXP2 in GBM. (C) Kaplan-Meir survival curve analysis reveals that lower miR-9-5p predicts poorer survival (110 GBM patients). (D) Kaplan-Meir survival curve analysis reveals that higher FOXP2 predicts poorer survival (110 GBM patients).